Where does Otto Bock Healthcare Lp rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Otto Bock Healthcare Lp ranks #4,215 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Otto Bock Healthcare Lp hold?

Otto Bock Healthcare Lp holds 85 US utility patents granted between 2015 and 2025, spanning 34 technology areas.

What is Otto Bock Healthcare Lp's Innovation Score?

Otto Bock Healthcare Lp has an Innovation Score of 52.0 out of 100 (top 11% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Otto Bock Healthcare Lp's patent grant rate increasing or decreasing?

Otto Bock Healthcare Lp's recent grant velocity is -76% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Otto Bock Healthcare Lp's patents?

Otto Bock Healthcare Lp's patents average 16.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Otto Bock Healthcare Lp patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Otto Bock Healthcare Lp

Q: What technology areas does Otto Bock Healthcare Lp focus on?

Otto Bock Healthcare Lp's top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 67 patents. Grants appear in 34 CPC subclasses total.

USPTO PatentsView assignee record - 85 granted patents across 34 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Otto ranks #4,215 of 50,000 tracked US assignees by granted-patent volume, with 85 patents across 34 technology areas.

#4,215
of 50,000 US assignees by volume: Top 11%
by Innovation Score (52.0/100): 16.4
avg claims per patent: -76%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4215 · US Corporation #4,215 · 85 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 85 grants
TOP-DECILE #4,215/50,000
PHOTO-FINISH Nobel Biocare Services
CPC-FOCUS A61F · 34 areas
INNOV-PAR 52.0/100
CLAIMS-RICH 16.4 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -76% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nobel Biocare Services Ag (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
DE LA RUE Internatio… · near

52
Excalibur IP · near

52
Industry-academic Co… · near

52
Other LAB · near

52
Otto Bock Healthcare · this assignee

52
3D Lighting Innovati… · lowest

7

What this shows Otto Bock Healthcare Lp stamps GRANTS-SMALL, TOP-DECILE, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, VEL-DROP, BOOK-FULL. Volume places it #4,215 of 50,000; Innovation Score 52.0/100 sits in the top 11% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Nobel Biocare Services Ag (±0 grants).

Portfolio overview

Otto Bock Healthcare Lp has been granted 85 US utility patents between 2015 and 2025, placing Otto Bock Healthcare Lp at #4,215 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 34 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.4 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Otto Bock Healthcare Lp is one of the more focused assignees in the PatentsView dataset. By volume, Otto sits between Nobel Biocare Services Ag (85 patents, rank #4,211) and SAGE Electrochromics, Inc. (85 patents, rank #4,219) - the closest US assignees by grant volume. The composite Innovation Score of 52.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 16 grants, compared with 68 in the 2015–2019 window, a -76% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Otto Bock Healthcare Lp's 16.4 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 34 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Nobel Biocare Ser…

85
O&M Halyard

85
Océ Holding B V

85
Omrix Biopharmace…

85
Pindrop Security

85
Polygroup Macau (…

85
Rotation Medical

85
SAGE Electrochrom…

85
Otto Bock Healthc… ◀

85

What this shows Otto holds 85 patents at rank #4,215, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Otto

By rank, the assignees closest to #4,215 in granted patent volume.

Leaders in A61F (Filters Implantable INTO Blood Vessels)

Other assignees with the most granted patents in Otto's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Otto, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (52 here).

DE LA RUE International Limited 52 Industry-academic Cooperation Foundation, Chosun University 52 Excalibur IP, Llc 52 Other LAB, Llc 52

Similar claim depth

Nearest assignees by average claims per patent (16.4 here).

Intouch Technologies, Inc. 16.4 avg Saudi Basic Industries Corporation 16.4 avg Boehringer Ingelheim Animal Health USA Inc. 16.4 avg Tigo Energy, Inc. 16.4 avg

Otto's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

52 Top 11% higher than 89% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Otto Bock Healthcare Lp patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	19	22.4%
2016	6	7.1%
2017	19	22.4%
2018	17	20.0%
2019	7	8.2%
2020	2	2.4%
2021	3	3.5%
2022	4	4.7%
2023	5	5.9%
2024	2	2.4%
2025partial year	1	1.2%

Which technologies does Otto Bock Healthcare Lp patent most?

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 67

B25J - MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES 7

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 6

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 5

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 3

H02K - DYNAMO-ELECTRIC MACHINES 3

G01L - MEASURING FORCE, STRESS, TORQUE, WORK, MECHANICAL POWER, MECHANICAL EFFICIENCY, OR FLUID PRESSURE 2

G01P - MEASURING LINEAR OR ANGULAR SPEED, ACCELERATION, DECELERATION, OR SHOCK; INDICATING PRESENCE, ABSENCE, OR DIRECTION, OF MOVEMENT 2

C08G - MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS 2

C08K - Use of inorganic or non-macromolecular organic substances as compounding ingredients 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

B62D - MOTOR VEHICLES; TRAILERS 2

F16F - SPRINGS; SHOCK-ABSORBERS; MEANS FOR DAMPING VIBRATION 1

H02J - CIRCUIT ARRANGEMENTS OR SYSTEMS FOR SUPPLYING OR DISTRIBUTING ELECTRIC POWER; SYSTEMS FOR STORING ELECTRIC ENERGY 1

F04B - POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS 1

Top 15 of 34 technology areas

Where it ranks

Overall rank by patents

#4,215

of 50,000 tracked assignees

Innovation Score

52.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.